Evolution of the Average Target: Medical Properties Trust, Inc.

Evolution of the Average Target - Medical Properties Trust, Inc.

Evolution of the Target Price: Medical Properties Trust, Inc.

Evolution of the Target Price - Medical Properties Trust, Inc.

Changes in Analyst Recommendations: Medical Properties Trust, Inc.

0b99.oy23KnbZGKffC-gkQ3sqKV0pwGa6XhhKy5Us4ZXMPaM.zXXWQzfpQMmlWsUJCglIGhdnly32FlY8pdh2gsGCf8WVG8ZkQuthke9t2A~69942aaa7eb4707e4488f4d43e40995a
08-17 BofA Securities Adjusts Medical Properties Trust Price Target to $4.25 From $5 MT
06-18 RBC Cuts Price Target on Medical Properties Trust to $4.50 From $5, Keeps Sector Perform, Speculative Risk MT
03-02 RBC Raises Price Target on Medical Properties Trust to $5 From $4.50, Keeps Sector Perform, Speculative Risk MT
30/06/25 RBC Lowers Price Target on Medical Properties Trust to $4.50 From $5, Keeps Sector Perform, Speculative Risk MT
12/03/25 BNP Paribas Exane Upgrades Medical Properties Trust to Outperform From Neutral, Raises Price Target to $9 From $5 MT
10/03/25 RBC Raises Price Target on Medical Properties Trust to $5 From $4, Keeps Sector Perform, Speculative Risk MT
13/09/24 Colliers Upgrades Medical Properties Trust to Buy From Neutral, Price Target is $6.50 MT
12/09/24 Truist Securities Raises Price Target on Medical Properties Trust to $6 From $5, Maintains Hold Rating MT
02/07/24 BNP Paribas Exane Downgrades Medical Properties Trust to Neutral From Outperform, Adjusts Price Target to $4 From $6 MT
30/05/24 Truist Adjusts Price Target on Medical Properties Trust to $5 From $4.50, Maintains Hold Rating MT
14/05/24 RBC Downgrades Medical Properties Trust to Sector Perform From Outperform, Price Target is $5 Amid Tenant-Related Concerns MT
14/05/24 RBC Downgrades Medical Properties Trust to Sector Perform From Outperform, Price Target is $5 MT
17/04/24 Deutsche Bank Upgrades Medical Properties Trust to Hold From Sell, Adjusts PT to $5 From $2 MT
08/04/24 Truist Securities Raises Price Target on Medical Properties Trust to $4.50 From $4, Maintains Hold Rating MT
01/03/24 BNP Paribas Exane Upgrades Medical Properties Trust to Outperform From Neutral, Price Target is $6 MT
20/02/24 RBC Cuts Price Target on Medical Properties Trust to $5 From $8 on Steward-Related Rent Disruption, Keeps Outperform, Speculative Risk MT
05/01/24 KeyBanc Downgrades Medical Properties Trust to Sector Weight From Overweight, Removes $15 Price Target Amid Uncertainty, Risks to Tenant Health MT
03/01/24 Mizuho Securities Adjusts Medical Properties Trust's Price Target to $7 From $9, Keeps Neutral Rating MT
28/11/23 RBC Cuts Price Target on Medical Properties Trust to $8 From $10, Keeps Outperform Rating MT
10/11/23 Stifel Downgrades Medical Properties Trust to Hold From Buy, Adjusts Price Target to $4.50 From $12 MT
16/10/23 Wells Fargo Downgrades Medical Properties Trust to Underweight From Equalweight, Cuts Price Target to $4 From $7 MT
31/08/23 Mizuho Downgrades Medical Properties Trust to Neutral From Buy, Adjusts Price Target to $9 From $18 MT
22/08/23 Barclays Adjusts Price Target on Medical Properties Trust to $10 From $12, Maintains Overweight Rating MT
21/08/23 JPMorgan Downgrades Medical Properties Trust to Underweight From Neutral, Adjusts Price Target to $7 From $9 MT
21/08/23 Analyst recommendations: Alphabet, AstraZeneca, FMC Corp, Target, Wise... Zonebourse

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+60.66%
+17.49%
+22.06%
+29.39%
+26.9%
+17.35%
+24.53%
+28.43%
+37.1%
+18.88%
Average +28.28%
Weighted average by Cap. +23.15%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
3.140USD
Average target price
5.125USD
Spread / Average Target
+63.22%
High Price Target
7.000USD
Spread / Highest target
+122.93%
Low Price Target
4.250USD
Spread / Lowest Target
+35.35%

Analyst Consensus Detail

Analyst consensus - Medical Properties Trust, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Medical Properties Trust, Inc.
Trader
Investor
Global
Quality
ESG MSCI
BBB
Ratings Surperformance© - Medical Properties Trust, Inc.
  1. Stock Market
  2. Stocks
  3. MPT Stock
  4. Consensus Medical Properties Trust, Inc.